Clinical Trial Update: A Clinical Study to Observe How Well That BAT8006 Works on Patients With Platinum Resistance Ovarian Cancer [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial evaluating BAT8006 for platinum-resistant epithelial ovarian cancer, fallopian tube cancer, and primary peritoneal cancer has been wi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Fallopian Tube Cancer
• Peritoneal Cancer
• Platinum-resistant Epithelial Ovarian Cancer

Drugs mentioned

• BAT8006

Snippet

Sponsor: Bio-Thera Solutions | Conditions: Platinum-resistant Epithelial Ovarian Cancer, Fallopian Tube Cancer | Phase 1, Phase 2 | Status: WITHDRAWN